Skip to main content
OpenTrials
Completed

NCT Number: NCT02907138

Medical Yoga for Patients With Stress-related Symptoms

The purpose of this study is to compare the effect of Medical Yoga as a group treatment, to conventional treatment provided by a physical therapist, for people with perceived stress-related symptoms.

Forty people are to be randomized to either:

1. Intervention Group - Medical Yoga, group treatment for eight weeks, 60 minutes per week, with the guidance of a physical therapist.

or 2. Control - treatment as usual (TAU) in physical therapy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stress-related Illness/Anxiety Anxiety Disorders Mental Disorders

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Narhalsan Gibraltar rehabmottagning

Gothenburg, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Perceived stress and anxiety, which could be expressed as for example as tension in the neck and shoulders, insomnia, anxiety and headaches.

Exclusion criteria

  • Do not understand Swedish (as group instructions need to be understood),
  • Pregnancy,
  • Psychotic symptoms,
  • Ongoing or physical therapy treatment the last three months,
  • Previously participated in Medical Yoga group.

Treatment and study plan

Medical Yoga

Other

Treatment as Usual (physical therapy)

Other

Primary outcomes

  1. Perceived Stress Scale (PSS)

    Time frame: baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session

    Outcome will be measured as change between baseline and follow-ups and between follow-ups. Total score will also be analysed between groups at follow-up(s).

Secondary outcomes

  1. Hospital Anxiety and Depression Scale (HADS)

    Time frame: baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session

  2. Health-related quality of Life; EQ5D

    Time frame: baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session

  3. Thorax excursion: Measured in centimeters with tape measure, chest size at the level of processus xiphoideus, the difference between the maximum inhalation and exhalation is registered

    Time frame: baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session

  4. Health-related quality of Life; EQ-VAS

    Time frame: baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session

Sponsors and collaborators

Lead sponsor

Maria Larsson

Other Gov

Registry information

Important dates

Study start
2016
Primary completion
2019
Study completion
2019
First posted
Sep 20, 2016
Registry last updated
Sep 16, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.